Agenda

AMCCBS-2023-register-3300x990

 

More session descriptions are coming soon.

 

Wednesday, March 8

2:30 – 5:30 PM EST
Best of Community Cancer Care🔻

This initiative provides guidance on the translation of new clinical and operational updates into patient care strategies by promoting collaboration between community oncology clinicians and cancer program administrators. This workshop will offer opportunities for discussion with leading oncology experts on the tools and resources in specific areas of oncology management that can be used to achieve effective cancer care delivery and improve the patient experience.

2:30 – 5:30 PM EST
Mental Health Summit🔻

A multistakeholder summit—in partnership with the American Psychosocial Oncology Society and Association of Oncology Social Work—focused on mental health in oncology. Participants will collaboratively discuss the current state of mental health in oncology, review and identify effective methods for addressing psychological distress, identify barriers to care for patients and caregivers experiencing psychological distress, and promote strategies to foster resilience and mitigate burnout among members of the cancer care team.

5:30 – 7:00 PM EST
Opening & Welcome Reception
 

Thursday, March 9

7:00 – 8:00 AM EST
Networking Breakfast with Table Talks
8:00 – 8:15 AM EST
Welcome
8:15 – 9:15 AM EST
Keynote Address: Precision Medicine: Stories from the CRISPR Revolution 🔻

Kevin-Davies-260x260Kevin Davies, PhD, Executive Editor of The CRISPR Journal and GEN Biotechnology; author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, Breakthrough: The Race for the Breast Cancer Gene, and Cracking the Genome; co-author of DNA: The Story of the Genetic Revolution.

The CRISPR revolution is barely ten years’ old but this astonishing genome editing technology has already earned a Nobel Prize for its developers and is having a profound impact in the clinic. Dozens of patients with sickle cell disease have been essentially cured and now this technology is being leveraged in many other genetic diseases and cancers. A growing number of therapies involve modified versions of CRISPR that are capable of precision gene editing—changing a single letter among three billion letters in the genetic code. The first FDA approval for a CRISPR therapy is imminent. But can this game-changing technology deliver safe and affordable precision medicine for patients? In this lively presentation, Dr Kevin Davies, author of Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, will discuss the origins, rivalries, breakthroughs, and scandals that have exhilarated and at times rocked the scientific and medical community. All this will be set against the backdrop of the 70th anniversary of the double helix, which we mark this spring.
More about the speaker

9:15 – 10:00 AM EST
Cancer Moonshot Update 🔻

Danielle M. Carnival, PhD, White House Cancer Moonshot Coordinator.

10:00 – 10:30 AM EST
Networking Break
10:30 AM – 12:30 PM EST
Four Workshop Choices Covering New Care Delivery Models, BI-Enabled Technology Solutions, Precision Medicine, and Payer-Driven Strategies 🔻

New Care Delivery Models

Facilitators: Steve Grubbs, MD, Director of Clinical Affairs and Cancer Care Delivery, American Society of Clinical Oncology; Christine Meek, Service Line Business Manager, Munson Healthcare; Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute

A facilitated workshop that takes a deep dive into telehealth and virtual care models, alternative payment models, partnership opportunities across care settings, service line optimization, and more. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

BI-Enabled Technology Solutions

Facilitators: Amy Ellis, Chief Operating Officer, Northwest Medical Specialties, PLLC; Douglas Flora, MD, LSSBB, Executive Medical Director, Oncology Services, St. Elizabeth Cancer Center; Jeff Hunnicutt, Chief Executive Officer, Highlands Oncology Group, PA; and Matthew Manning, MD, FASTRO, Radiation Oncologist, Cone Health Cancer Center

A facilitated workshop that takes a deep dive into predictive modeling and data analytics that identify opportunities to reduce costs and improve revenue cycle management; technology platforms and AI-enabled algorithms to optimize scheduling and resource utilization; and data collection and reporting to support participation in alternative payment models, meet payer-mandated requirements, and improve social determinants of health. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference .

Precision Medicine

Facilitators: Sigrun Hallmeyer, MD, Director, Advocate Lutheran General Hospital, Lutheran General Cancer Institute; Leigha Senter-Jamieson, MS, CGC, Licensed Genetic Counselor and Associate Professor, Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University; Emily Z. Touloukian, DO, Medical Oncologist and Hematologist and President, Coastal Cancer Center

A facilitated workshop that takes a deep dive into patient identification and navigation processes and best practices; workforce innovations, including development of new roles like precision medicine stewards and navigators; and access and policy actions to take to ensure equitable access for all. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

Strategies to Mitigate Payer-Driven Challenges

Facilitators: Jorge García, PharmD, MS, MHA, MBA, FACHE, Assistant Vice President - System Oncology Pharmacy Service Line, Miami Cancer Institute, Baptist Health South Florida; Alti Rahman, MHA, MBA, CSSBB, Texas Society of Clinical Oncology Board Member and Practice Administrator, Oncology Consultants; Susan Wagner, MSN, RN, OCN, Executive Director of Clinical Strategy, Oncology Consultants

A facilitated workshop that takes a deep dive into processes to mitigate burdensome payer requirements like pre-authorizations; strategies for negotiating with payers to change policies that restrict access to care; and policy and advocacy actions to help limit payer-driven strategies like excessive step therapy protocols, use of pharmacy benefit managers, white- and brown-bagging, and policies that mandate where treatment is delivered. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

12:30 – 1:30 PM EST
Networking Roundtable Lunch
1:30 – 2:15 PM EST
The Role of Oncology and Primary Care in Multi-Cancer Early Detection 🔻

Tomasz Beer, MD, FACP, Chief Medical Officer and Vice President, Multi-Cancer Early Detection, Exact Sciences

2:15 – 3:15 PM EST
Technology-Driven Industry Showcases
3:15 – 3:30 PM EST
Networking Break
3:30 – 5:30 PM EST
Four Workshop Choices covering AI-Enabled Clinical Decision Support, Research and Clinical Trials, Staffing and Workforce Strategies, and Patient Engagement Strategies 🔻

AI-Enabled Clinical Decision Support Tools

Facilitators: Douglas Flora, MD, LSSBB, Executive Medical Director, Oncology Services, St. Elizabeth Cancer Center; Matthew Manning, MD, FASTRO, Radiation Oncologist, Cone Health Cancer Center; Olalekan Ajayi, PharmD, MBA, Chief Operating Officer, Highlands Oncology Group, PA

A facilitated workshop that takes a deep dive into best practices for leveraging this technology to help clinicians work smarter and faster, reduce burnout, and mitigate workforce shortages by better utilization of APPs; standardize care across clinic sites and improve care of at-risk and underserved patients; and build capacity and plan for the future. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

Research and Clinical Trials

Facilitators: Jennie Crews, MD, MMM, FACP, FACCC, Associate Chief Medical Officer, Ambulatory Care, Stanford Health Care and Chief Medical Officer, University HealthCare Associates, Stanford Cancer Center; Christa M. Braun-Inglis, MS, APRN, FNP-BC, AOCNP, Nurse Practitioner/Assistant Researcher, University of Hawaii Cancer Center; Randall A. Oyer, MD, Medical Director, Penn Medicine Lancaster General Health, Ann B. Barshinger Cancer Institute

A facilitated workshop that takes a deep dive into putting the ASCO/ACCC site assessment tool and Just ASK! tools into practice to increase diversity in clinical trials, research collaboration opportunities, and new models like decentralized and virtual clinical trials. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

Staffing Models and Workforce Strategies

Facilitators: Ellen Feinstein RD, MHA, LFACHE, Vice President, Cancer Service Line Administration, Advocate Aurora Health; Krista Nelson, MSW, LCSW, OSW-C, FAOSW, Senior Oncology Social Worker and Program Manager, Cancer Support Services & Compassion, Providence Health & Services; Barbara Schmidtman, PhD, Vice President, Operations, Corewell Health Lakeland Hospital; Amy Smith, RN, BSN, Cancer Center Director, Ivinson Memorial Hospital, Meredith and Jeannie Ray Cancer Center

A facilitated workshop that takes a deep dive into best practices for recruitment and retention, mentorship and succession models that support diverse leadership, and supportive care programs and policies that address burnout and resiliency. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

Patient Engagement Strategies

Facilitators: Lailea Noel, PhD, MSW, Assistant Professor, Steve Hicks School of Social Work and Assistant Professor of Oncology & Health Social Work, The University of Texas Dell Medical School, LIVESTRONG Cancer Institutes; Renea Duffin, MPA, Vice President, Cancer Support and Outreach, Mary Bird Perkins Cancer Center - Baton Rouge; Nicole Weis, MA, Senior Service Line Director, University of Minnesota Cancer Care

A facilitated workshop that takes a deep dive into best practices for coalition building and outreach strategies to at-risk and underserved communities, shared decision-making and health literacy, and cost of care discussions and financial navigation support. Outcomes, including solutions to key challenges and actionable next steps, will be captured and used to develop a comprehensive report for meeting participants post-conference.

 

Friday, March 10

7:30 – 8:30 AM EST
Breakfast and House of Delegates Meeting
8:30 – 9:15 AM EST
Keynote Address: Robots, Biologics, and Advocates: Lessons from the Pharmacy 🔻

Andre-Harvin-235x235Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center

While oncology is all too familiar with the skyrocketing costs of drugs and other anti-cancer treatment regimens, learn how a well-tuned pharmacy team can help your cancer program or practice realize cost savings and efficiencies with technology like robotic pharmacists, innovative biosimilar strategies, use of dose-banding, and alignment of infusion nurse and pharmacist scheduling to streamline operations and improve the patient experience.
More about the speaker

9:15 – 9:45 AM EST
Emergent Payment Issues in Oncology 🔻

Foley & Lardner, LLP.

9:45 – 10:15 AM EST
All Hands on Deck! 🔻

Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute; Una Hopkins, RN, FNP-BC, DNP, Director of Research, Montefiore Einstein Center Cancer Care

How do you plan and survive a workforce strike? Two healthcare systems share “tales from the trenches,” including the operational strategies that were put in place to keep the doors open for patients with cancer when their nurses walked out.

10:15 – 10:45 AM EST
Networking Break

 

10:45 – 11:15 AM EST
Regulatory Considerations Post-PHE 🔻

Foley & Lardner, LLP

11:15 AM – 12:45 PM EST
Succeeding Under Value-Based Care 🔻

Jeff Hunnicutt, Chief Executive Officer, Highlands Oncology Group, PA; Mark Liu, MHA, Senior Director of Oncology Strategy, Transformation & Analytics, Oncology Service Line, Mount Sinai Health System & Tisch Cancer Institute; Anne Marie Rainey, MSN, RN, CHC, Compliance and Quality Control Officer, Clearview Cancer Institute; Barry Russo, MHA, Chief Executive Officer, The Center for Cancer & Blood Disorders

Members of the ACCC Alternative Payment Coalition (APMC) discuss strategies for developing and operationalizing alternative payment models with private payers that will strengthen the cancer service line and then turn the discussion to a practical evaluation of the new Enhancing Oncology Model (EOM).

12:45 – 1:30 PM EST
Networking Lunch

 

Last updated 12.21.2022. | Agenda subject to change.